development
-
Biologics
SINTX Announces Successful FDA 510(k) Pre-Submission Meeting for Silicon Nitride-PEEK Composite Spine Implants
SALT LAKE CITY, Sept. 08, 2022 (GLOBE NEWSWIRE) — SINTX Technologies, Inc. (www.sintx.com) (NASDAQ: SINT) (“SINTX” or the “Company”), an original…
Read More » -
Financial
Ganymed Robotics Raises €21M to Complete the Development of Its Next Generation Surgical Robot and Prepare for a Commercial Launch
The oversubscribed first close of Series B funding was led by Cathay Health, joined by Credit Mutuel Innovation, Kurma Partners…
Read More » -
Spine
Spineway-new development dynamics and confirmation of strategy
Ecully , June 24 , 2022 New momentum for a strong comeback on the French market Successful participation in the SFCR CongressConfirmation of the development…
Read More » -
Biologics
SetBone Medical Announces $1.6 Million Financing
TEL AVIV, Israel, Jan. 26, 2022 /PRNewswire/ — SetBone Medical Ltd., a company that has developed a novel bone cement for the treatment…
Read More » -
Financial
Titan Medical Receives Final Milestone Payment and Retires Senior Secured Loan From Medtronic
January 26, 2022 TORONTO–(BUSINESS WIRE)–Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical technology company focused on the design and…
Read More » -
Financial
Titan Medical Receives License Fee of $10 Million Upon Achievement of Milestone Under Medtronic Development Agreement
Completion of Second Technical Milestone Marks Third Achievement Under Development and License Agreement TORONTO, May 28, 2021 (GLOBE NEWSWIRE) —…
Read More » -
Extremities
In2Bones USA and Invibio Announce R&D, Development and Manufacturing Agreement
Carbon-reinforced PEEK-OPTIMA™ biomaterial to enhance implant performance November 17, 2020 MEMPHIS, Tenn.–(BUSINESS WIRE)–In2Bones Global, Inc., a leading global manufacturer of…
Read More »